This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US Court of Appeals: District of Columbia - FTC v. Boehringer Ingelheim Pharmaceuticals [Boehringer final brief]

( October 3, 2013, 22:00 GMT | Official Statement) -- MLex Summary: Boehringer Ingelheim has filed its final brief in the Federal Trade Commission's appeal from a decision holding that documents the agency sought to obtain from it regarding agreements with generic drug manufacturer Barr Pharmaceuticals over the drugs Mirapex and Aggrenox were protected work product and the company therefore did not have to produce them. Boehringer argues that the district court correctly applied the legal standard and "reasonably held that Boehringer’s workproduct documents were prepared at the direction of counsel to assist in making strategic decisions about the patent lawsuits and their settlements and that the documents would not have been prepared absent the litigation and settlements."See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections